(PharmaNewsWire.Com, June 22, 2021 ) The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth.
“The metallic biomaterials segment dominated the dental biomaterials market”
Based on type, the dental biomaterials market is broadly segmented into metallic, ceramic, polymeric, metal-ceramic, and natural biomaterials. In 2018, the metallic biomaterials segment accounted for the largest share of the dental biomaterials market. The large share of this segment can be attributed to the increasing penetration of dental implants and the wide applications of metallic biomaterials in dentistry.
“By application, the implantology segment held the largest market share in 2018.”
Based on application, the dental biomaterials market is segmented into implantology, prosthodontics, orthodontics, and other applications. In 2018, the implantology application segment accounted for the largest share of the dental biomaterials market. The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry, and increasing disposable incomes in developing countries.
“Europe dominated the market in 2018.”
The dental biomaterials market is broadly segmented into five major regions North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the largest share of the dental biomaterials market in 2018. Key factors attributed to the large share of dental biomaterials market in Europe are the growing geriatric population, increasing government expenditure on oral healthcare, higher adoption of the dental biomaterials to manufacture implants and other dental products, and the growing number of dental hospitals and clinics.
The prominent players in the dental biomaterials market include Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
